Product NDC: | 0054-4550 |
Proprietary Name: | Methotrexate Sodium |
Non Proprietary Name: | Methotrexate Sodium |
Active Ingredient(s): | 2.5 mg/1 & nbsp; Methotrexate Sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0054-4550 |
Labeler Name: | Roxane Laboratories, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040054 |
Marketing Category: | ANDA |
Start Marketing Date: | 19940801 |
Package NDC: | 0054-4550-15 |
Package Description: | 36 TABLET in 1 BOTTLE, PLASTIC (0054-4550-15) |
NDC Code | 0054-4550-15 |
Proprietary Name | Methotrexate Sodium |
Package Description | 36 TABLET in 1 BOTTLE, PLASTIC (0054-4550-15) |
Product NDC | 0054-4550 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Methotrexate Sodium |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19940801 |
Marketing Category Name | ANDA |
Labeler Name | Roxane Laboratories, Inc |
Substance Name | METHOTREXATE SODIUM |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |